Form CORRESP - Correspondence:
SEC Accession No. 0000950170-23-016686
Filing Date
2023-05-02
Accepted
2023-05-02 16:13:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 21148
  Complete submission text file 0000950170-23-016686.txt   22073
Mailing Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations